Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -97,395 | N/A | N/A |
| Depreciation Amortization | 2,841 | N/A | N/A |
| Income taxes - deferred | -5,565 | N/A | N/A |
| Accounts payable and accrued liabilities | 658 | N/A | N/A |
| Other Working Capital | 45,633 | N/A | N/A |
| Other Operating Activity | 31,695 | 0 | 0 |
| Operating Cash Flow | $-22,133 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -136,694 | N/A | N/A |
| PPE Investments | -6,580 | N/A | N/A |
| Sale Of Investment | 57,984 | N/A | N/A |
| Investing Cash Flow | $-85,290 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 117,725 | N/A | N/A |
| Common Stock Repurchased | -4,102 | N/A | N/A |
| Financing Cash Flow | $113,623 | $N/A | $N/A |
| Beginning Cash Position | 50,024 | N/A | N/A |
| End Cash Position | 56,224 | N/A | N/A |
| Net Cash Flow | $6,200 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -22,133 | N/A | N/A |
| Capital Expenditure | -6,580 | N/A | N/A |
| Free Cash Flow | -28,713 | 0 | 0 |